Drug Topics June 7, 2024
In an abstract presented at ENDO 2024, researchers addressed practitioners’ current knowledge of CGM and their experience prescribing in low-income communities.
As continuous glucose monitoring (CGM) technology advances and becomes more available, it’s important that low-income communities attain better access and education regarding its benefits.
“More than 100 million Americans have prediabetes or diabetes, with more than 10 million using insulin. Hence, access to CGM is crucial for patients for better management. Despite the benefits, many factors play a role in limiting their use, including prescription, cost, insurance coverage, social factors, willingness of the patients, discomfort, and decreased knowledge,” wrote authors of the abstract presented at ENDO 2024.1
CGM is becoming the standard of care for patients with diabetes to...
Today's Sponsors
Today's Sponsor